Biomechanics of Metastatic Defects in Bone
Public ClinicalTrials.gov record NCT02109952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Purpose of This Study is to Monitor Fracture Risk Associated With Bone Tumors in Cancer Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to monitor fracture risk associated with bone tumors in cancer patients. Previous studies from our lab have suggested that it is possible to compute the mechanical strength of bones with tumors using computed tomography (CT) scans, which are like three-dimensional X-ray pictures of the affected bones. The next step in determining the usefulness of this type of strength analysis is to see if we can accurately predict who is at risk for bone fracture and which patients are at high risk of fractures. This non-invasive analysis may help physicians determine the best treatment to reduce the risk of an impending bone fracture in the future.
Study identification
- NCT ID
- NCT02109952
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 245 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 20 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Dec 30, 2025
- Completion
- Dec 30, 2025
- Last update posted
- May 8, 2024
2009 – 2025
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alvin and Lois Lapidus Cancer Center, Sinai Hospital of Baltimore, Inc | Baltimore | Maryland | 21215 | — |
| Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School | Boston | Massachusetts | — | — |
| Department of Orthopaedic Surgery, University of Minnesota Medical Center | Minneapolis | Minnesota | — | — |
| Department of Orthopedic Surgery, Upstate Medical University | Syracuse | New York | 13057 | — |
| Department of Orthopaedic Surgery, Rhode Island Hospital | Providence | Rhode Island | 02905 | — |
| Section of Orthopaedic Oncology, University of Texas M. D. Anderson Cancer Center | Houston | Texas | — | — |
| Edwards Comprehensive Cancer Center, Marshall University | Huntington | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02109952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2024 · Synced Sep 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02109952 live on ClinicalTrials.gov.